Skip to content
nejm.org· Xavier Mariette Thomas Grader-Beck Stephanie Finzel Elena Schiopu Athena Papas Valerie Devauchelle-Pensec Monika Sopala Xiaofeng Zeng Ghaith Noaiseh Tsutomu Takeuchi Uma Kumar Josef Hermann Hiroki Ozawa Robert Fox Susan Zong Deepak Narayanswamy Xiaomei Li Wen-Lin Luo Janice Woznicki Laurie Debonnett Xuan Zhu Linchen He Franziska Matzkies Angelika Jahreis Devendra Kumar Jain Brian Porter Carol Lau Thomas Dörner Sara S. McCoy Simon J. Bowman and Wolfgang Hueberthe NEPTUNUS-1 and NEPTUNUS-2 Investigators*·· 1 day agoPickScore60

Ianalumab for the Treatment of Patients with Sjögren’s Disease

Ianalumab for the Treatment of Patients with Sjögren’s Disease

In brief

The New England Journal of Medicine published a study of ianalumab for the treatment of patients with Sjögren's disease. The article appears in Volume 395, Issue 16, pages 1585-1599, DOI 10.1056/NEJMoa2601088.

Why it matters

NEJM published a study of ianalumab in Sjögren's disease

Source: nejm.org · nejm.org

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org